×
返回 Agendas
DEVELOP Risk-Based Monitoring Strategies to INNOVATE Study Oversight and ADVANCE Study Execution
Session Chair(s)
Lynn King, MHA
Consultant
United States
This forum will explore the lessons learned from a case study of developing and implementing a risk-based monitoring strategy for a 30-site global trial. The collaborative sponsor/contract research organization process and implications will be presented and discussed.
Learning Objective : Describe risk-based monitoring strategy for 30-site global trial; Discuss lessons learned from strategy development and implementation; Evaluate potential improvements to improve strategy development process.
Speaker(s)
Panelist
William L Tobia, MBA, MS
GlaxoSmithKline, United States
Lead Clinical Instructor
注册方法
Registration override should work.